Abstract
Systemic amyloidoses are a wide group of diseases with different courses, treatments and prognoses. Unequivocal typing of amyloid deposits is important for correct diagnosis and appropriate treatment. At present, the most effective therapeutic approach is based on eliminating the supply of amyloidogenic precursor. New effective therapies will stem from our improved knowledge of the molecular mechanisms of amyloidosis.
| Original language | English |
|---|---|
| Pages (from-to) | 104-105 |
| Number of pages | 2 |
| Journal | Netherlands Journal of Medicine |
| Volume | 62 |
| Issue number | 4 |
| Publication status | Published - Apr 2004 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Systemic amyloidosis : Are we moving ahead? / Merlini, G.
In: Netherlands Journal of Medicine, Vol. 62, No. 4, 04.2004, p. 104-105.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Systemic amyloidosis
T2 - Are we moving ahead?
AU - Merlini, G.
PY - 2004/4
Y1 - 2004/4
N2 - Systemic amyloidoses are a wide group of diseases with different courses, treatments and prognoses. Unequivocal typing of amyloid deposits is important for correct diagnosis and appropriate treatment. At present, the most effective therapeutic approach is based on eliminating the supply of amyloidogenic precursor. New effective therapies will stem from our improved knowledge of the molecular mechanisms of amyloidosis.
AB - Systemic amyloidoses are a wide group of diseases with different courses, treatments and prognoses. Unequivocal typing of amyloid deposits is important for correct diagnosis and appropriate treatment. At present, the most effective therapeutic approach is based on eliminating the supply of amyloidogenic precursor. New effective therapies will stem from our improved knowledge of the molecular mechanisms of amyloidosis.
UR - http://www.scopus.com/inward/record.url?scp=4143091477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4143091477&partnerID=8YFLogxK
M3 - Article
VL - 62
SP - 104
EP - 105
JO - Netherlands Journal of Medicine
JF - Netherlands Journal of Medicine
SN - 0300-2977
IS - 4
ER -